左右半结肠癌临床病理特点差异分析

doi:10.3877/cma.j.issn.1674-3946.2019.05.012

目的

探讨左右半结肠癌临床病理特点的差异。

方法

回顾性分析2012年至2017年间收治的左右半结肠癌患者292例资料，以横结肠中段为分界，分为左半结肠癌142例(LCC组)，右半结肠癌150例(RCC组)。采用spss17软件进行统计处理，临床病理特征数据用(±s)表示，独立样本t检验；临床基本特征采用卡方检验，P<0.05为差异有统计学意义。

结果

RCC组中大于65岁的患者比例较高。LCC组患者比RCC组患者更容易接受急诊手术(14.8%比7.3% P＝0.042)。左右半结肠癌患者中在肿瘤T4分期、阳性淋巴结数目、清扫淋巴结总数差异均存在统计学意义(P<0.05)：RCC组中淋巴结转移(阳性淋巴结)的数量明显高于LCC患者(P＝0.034)。淋巴结清扫的总数在RCC组(21.8±8.9)枚也显著多于LCC组(16.4±6.8)枚，(P<0.01)。

结论

左右半结肠癌是两种不同实体疾病，两者临床病理特点具有显著差异，右半结肠癌患者更倾向于区域内淋巴结的转移。

关键词: 结肠肿瘤, 病理学，临床, 对比研究

Objective

To investigate the difference of clinicopathological characteristics between left and right colon cancer.

Method

Retrospective analysis were performed in 292 patients with left or right colon cancer from 2012 to 2017, of whom 142 cases of left colon cancer were divided into LCC group and 150 cases of right colon cancer into RCC group. Statistical analysis was carried out by using spss17 software. The clinicopathological characteristics were expressed as (±s) and were examined by independent t test. The basic clinical features were examined by chi square test. A P value of <0.05 was considered as statistically significant.

Results

The proportion of patients over 65 years old was higher in RCC group. Patients in LCC group was more likely to undergo emergency surgery than patients in RCC group (14.8% vs. 7.3% P=0.042). There were significant differences in T4 staging, number of positive lymph nodes, total number of harvested lymph nodes, and lymph node metastasis rate between the two groups respectively (P<0.05). In RCC group, the number of lymph node metastases (positive lymph nodes) was significantly higher than that in LCC patients (P=0.034). The total number of harvested lymph nodes in RCC group of (21.8±8.9) was also significantly higher than (16.4±6.8) in LCC group (P<0.01).

Conclusions

The left and right colon cancer are different kinds of tumor diseases. The clinicopathological characteristics of them are significantly different. Patients with right colon cancer are more likely to have regional lymph node metastasis.

Key words: Colonic neoplasms, Pathology, clinical, Comparative study

表1 292例左右半结肠癌两组患者的临床基本特征比较[例(%)]

临床特征		RCC(n＝150)	LCC(n＝142)	χ²	P
性别		?	?	?	?
?	男	91(60.7)	84(59.2)	0.069	0.792
?	女	59(39.3)	58(40.8)	0.069	0.792
年龄		?	?	?	?
?	<65岁	62(41.3)	75(52.8)	3.862	0.049
?	≥65岁	88(58.7)	67(47.2)	3.862	0.049
手术方式比		?	?	?	?
?	择期	139(92.7)	121(85.2)	4.155	0.042
?	急诊	11(7.3)	21(14.8)	4.155	0.042

表1 292例左右半结肠癌两组患者的临床基本特征比较[例(%)]

临床特征		RCC(n＝150)	LCC(n＝142)	χ²	P
性别		?	?	?	?
?	男	91(60.7)	84(59.2)	0.069	0.792
?	女	59(39.3)	58(40.8)	0.069	0.792
年龄		?	?	?	?
?	<65岁	62(41.3)	75(52.8)	3.862	0.049
?	≥65岁	88(58.7)	67(47.2)	3.862	0.049
手术方式比		?	?	?	?
?	择期	139(92.7)	121(85.2)	4.155	0.042
?	急诊	11(7.3)	21(14.8)	4.155	0.042

表2 292例左右半结肠癌两组患者的临床病理特征比较[(±s)，例(%)]

病理学特征		RCC(n＝150)	LCC(n＝142)	统计值	P值
肿瘤直径(cm)		?	?	?	?
?	≥5	75(50.0)	79(55.6)	0.929	0.335
?	<5	75(50.0)	63(44.4)	0.929	0.335
阳性淋巴结转移(枚)		5.7±2.6	2.9±1.6	4.499	0.034
平均清扫淋巴结(个)		21.8±8.9	16.4±6.8	6.504	<0.01
淋巴结转移率		0.1±0.2	0.1±0.1	1.046	0.017
pT分期(%)		?	?	?	?
?	T1	7(4.7)	5(3.5)	?	0.043
?	T2	18(12.0)	29(20.4)	?
?	T3	50(33.3)	52(36.6)	?
?	T4	75(50.0)	56(39.5)	?
远处转移		?	?	?	?
?	M0	148(98.7)	137(96.5)	1.492	0.222
?	M1	2(1.3)	5(3.5)	1.492	0.222

表2 292例左右半结肠癌两组患者的临床病理特征比较[(±s)，例(%)]

病理学特征		RCC(n＝150)	LCC(n＝142)	统计值	P值
肿瘤直径(cm)		?	?	?	?
?	≥5	75(50.0)	79(55.6)	0.929	0.335
?	<5	75(50.0)	63(44.4)	0.929	0.335
阳性淋巴结转移(枚)		5.7±2.6	2.9±1.6	4.499	0.034
平均清扫淋巴结(个)		21.8±8.9	16.4±6.8	6.504	<0.01
淋巴结转移率		0.1±0.2	0.1±0.1	1.046	0.017
pT分期(%)		?	?	?	?
?	T1	7(4.7)	5(3.5)	?	0.043
?	T2	18(12.0)	29(20.4)	?
?	T3	50(33.3)	52(36.6)	?
?	T4	75(50.0)	56(39.5)	?
远处转移		?	?	?	?
?	M0	148(98.7)	137(96.5)	1.492	0.222
?	M1	2(1.3)	5(3.5)	1.492	0.222

[1]	郑民华，马君俊．不断提高腹腔镜右半结肠癌根治规范化水平[J/CD]．中华普外科手术学杂志：电子版，2015，9(1): 1－3.
[2]	朱信强，管文贤. 同时性结直肠癌肝转移危险因素分析[J]. 现代肿瘤医学，2017，25(6): 911－914.
[3]	张海璐，邓婷，白明，等．左右半结肠癌临床特点及生存预后的比较[J]．中国老年学杂志，2015，9(1): 2446－2447.
[4]	Shen H,Yang J,Huang Q, et al. Different treatment strategies and molecular features between right－sided and left－sided colon cancers[J]. World J Gastroenterol, 2015, 21(21): 6470－6478.
[5]	卫洪波，黄江龙．腹腔镜右半结肠癌扩大切除术意义的纷争[J/CD]．中华普外科手术学杂志(电子版)，2018，12(3): 189－193.
[6]	Hussain M,Waqas O,Hassan U, et al.Right－Sided and Left－Sided Colon Cancers are Two Distinct Disease Entities: an Analysis of 200 Cases in Pakistan[J]. Asian Pac J Cancer Prev, 2016, 17(5): 2545－2548.
[7]	A Cienfuegos J,Baixauli J,Arredondo J, et al. Clinico－pathological and oncological differences between right and left－sided colon cancer (stages I－III): analysis of 950 cases[J]．Rev Esp Enferm Dig, 2018, 110(3): 138－144.
[8]	Di J,Zhuang M,Yang H, et al. Clinical significance of circulating immune cells in left－ and right－sided colon cancer[J]. Peer J, 2017, 5: e4153－e4153.
[9]	Lee GH,Malietzis G,Askari A, et al. Is right－sided colon cancer different to left－sided colorectal cancer? － a systematic review[J]. Eur J Surg Oncol, 2015, 41(3): 300－308.
[10]	A Cienfuegos J,Baixauli J,Arredondo J, et al. Clinico－pathological and oncological differences between right and left－sided colon cancer (stages I－III): analysis of 950 cases[J]. Rev Esp Enferm Dig, 2018, 110(3): 138－144.
[11]	Kim SE,Paik HY,Yoon H, et al.Sex－ and gender－specific disparities in colorectal cancer risk [J]．World J Gastroenterol, 2015 , 21(17): 5167－5175.
[12]	Quirt JS,Nanji S,Wei X, et al. Is there a sex effect in colon cancer? Disease characteristics, management, and outcomes in routine clinical practice[J]．Curr Oncol, 2017 , 24(1): e15－ e23.
[13]	Hffken N,Leichsenring J,Reinacher－Schick A．[Clinically relevant, gender－specific differences in colorectal carcinoma (CRC)] [J]．Z Gastroenterol, 2015 , 53(8): 782－788.
[14]	Gatot I,Chikman B,Shapira Z, et al. [A COMPARATIVE STUDY OF THE PATHOLOGICAL CHARACTERISTICS OF RIGHT SIDED VERSUS LEFT SIDED COLON CANCER] [J]．Harefuah, 2018, 157(5): 292－295.
[15]	Lim DR,Kuk JK,Kim T, et al.Comparison of oncological outcomes of right－sided colon cancer versus left－sided colon cancer after curative resection: Which side is better outcome? [J]. Medicine, 2017, 96(42): e8241－e8241.
[16]	Rutter CM,Knudsen AB,Marsh TL, et al. Validation of Models Used to Inform Colorectal Cancer Screening Guidelines: Accuracy and Implications[J]．Med Decis Making, 2016 , 36(5): 604－614.
[17]	Oistamo E,Hjern F,Blomqvist L, et al. Emergency management with resection versus proximal stoma or stent treatment and planned resection in malignant left－sided colon obstruction[J]. World J Surg Oncol, 2016, 14(1): 232－232.
[18]	Mik M,Berut M,Dziki L, et al. Right－ and left－sided colon cancer － clinical and pathological differences of the disease entity in one organ[J]. Arch Med Sci, 2017, 13(1): 157－162.
[19]	蔡东汉，官国先，刘星，等．左半结肠癌淋巴结转移规律的临床分析[J]. 中华胃肠外科杂志, 2016 , 19 (6) : 659－663
[20]	Rao A,Dadras M,Razzak MA, et al. Effect of Lymph Node Retrieval and Ratio on the Long－Term Survival and Recurrence of Colon Cancer[J]. J Coll Physicians Surg Pak, 2016 , 26(6): 467－470.
[21]	孟祥军，方超，王存，等. 淋巴结阳性率对Ⅲ期结直肠癌预后的影响[J]. 中国普外基础与临床杂志，2016，23(11): 1353－1357.
[22]	Hussain M,Waqas O,Hassan U, et al. Right－Sided and Left－Sided Colon Cancers are Two Distinct Disease Entities: an Analysis of 200 Cases in Pakistan[J]. Asian Pac J Cancer Prev, 2016, 17(5): 2545－2548.
[23]	Bertelsen CA,Kirkegaard－Klitbo A,Nielsen M, et al. Pattern of Colon Cancer Lymph Node Metastases in Patients Undergoing Central Mesocolic Lymph Node Excision: A Systematic Review[J]. Dis Colon Rectum. 2016 , 59(12): 1209－1221.
[24]	Liang H,Deng J．Evaluation of rational extent lymphadenectomy for local advanced gastric cancer[J]. Chin J Cancer Res. 2016 , 28(4): 397－403.
[25]	Jian－Hui C,Shi－Rong C,Hui W, et al. Prognostic value of three different lymph node staging systems in the survival of patients with gastric cancer following D2 lymphadenectomy[J]. Tumour Biol, 2016, 37(8): 11105－11113.

[1]	伍先权, 张立果, 周璇, 梁建深. 乳腺包裹性乳头状癌的临床病理与手术策略联系[J/OL]. 中华普通外科学文献(电子版), 2024, 18(04): 294-297.
[2]	李怡泉, 谢宇斌, 胡宏, 张燕茹, 陈图锋. 基于生物信息学分析HDAC8在结肠癌中的临床意义及其与免疫浸润的关系[J/OL]. 中华普通外科学文献(电子版), 2024, 18(04): 275-281.
[3]	崔宏帅, 冯丽明, 东维玲, 韩博. 腹腔镜右半结肠癌D3根治术+IGLN清扫术治疗局部进展期结肠肝曲癌的临床效果研究[J/OL]. 中华普外科手术学杂志(电子版), 2024, 18(05): 566-569.
[4]	丁志翔, 于鹏, 段绍斌. 血浆BRAF基因检测对腹腔镜右半结肠癌D3根治术中行幽门淋巴结清扫的指导价值[J/OL]. 中华普外科手术学杂志(电子版), 2024, 18(05): 570-573.
[5]	王维花, 王楠, 乔庆, 罗红. 完全腹腔镜右半结肠癌切除术两种腔内消化道重建方案对比研究[J/OL]. 中华普外科手术学杂志(电子版), 2024, 18(05): 574-577.
[6]	李晓鸥, 杨鹤鸣, 王国栋, 林海冠, 杨建武. 不同入路腹腔镜左半结肠癌根治术治疗效果对比[J/OL]. 中华普外科手术学杂志(电子版), 2024, 18(04): 377-380.
[7]	孙龙凤, 侯高峰, 王幼黎, 刘磊. 腹腔镜下右半结肠癌D3根治术中SMA或SMV入路的选择[J/OL]. 中华普外科手术学杂志(电子版), 2024, 18(04): 438-441.
[8]	金田力, 袁文正, 付涛. 单孔腹腔镜右半结肠癌根治术后尿管拔除时机探讨[J/OL]. 中华普外科手术学杂志(电子版), 2024, 18(03): 271-274.
[9]	杜彦斌, 黄涛, 寇天阔, 石英. 双镜联合根治术与腹腔镜根治术在早期结肠癌患者中的应用效果[J/OL]. 中华普外科手术学杂志(电子版), 2024, 18(03): 275-278.
[10]	何慧玲, 鲁祖斌, 冯嘉莉, 梁声强. 术前外周血NLR和PLR对结肠癌术后肝转移的影响[J/OL]. 中华肝脏外科手术学电子杂志, 2024, 13(05): 682-687.
[11]	关国欣, 罗福文. 结肠癌合并急性梗阻的个性化处理[J/OL]. 中华结直肠疾病电子杂志, 2024, 13(06): 459-463.
[12]	石阳, 于剑锋, 曹可, 翟志伟, 叶春祥, 王振军, 韩加刚. 可扩张金属支架置入联合新辅助化疗治疗完全梗阻性左半结肠癌围手术期并发症分析[J/OL]. 中华结直肠疾病电子杂志, 2024, 13(06): 464-471.
[13]	朱军, 宋家伟, 乔一桓, 郭雅婕, 刘帅, 姜玉, 李纪鹏. M2型巨噬细胞特征基因与结肠癌免疫微环境研究[J/OL]. 中华结直肠疾病电子杂志, 2024, 13(04): 303-311.
[14]	靳英, 付小霞, 陈美茹, 袁璐, 郝力瑶. CD147调控MAPK信号通路对结肠癌细胞增殖和凋亡的影响及机制研究[J/OL]. 中华临床医师杂志(电子版), 2024, 18(05): 474-480.
[15]	傅新露, 李之岳, 卢丹. 妊娠合并结肠癌穿孔致脓毒症休克一例并文献复习[J/OL]. 中华产科急救电子杂志, 2024, 13(04): 227-231.

阅读次数

全文

摘要

选择文件类型/文献管理软件名称

选择包含的内容

Clinical analysis of the clinicopathological characteristics of left and right colon cancer

模态框（Modal）标题

选择文件类型/文献管理软件名称

选择包含的内容

Clinical analysis of the clinicopathological characteristics of left and right colon cancer